Metabolic Syndrome Resolved within Two Years is Still a Risk Factor for Kidney Cancer
The prevalence of metabolic syndrome (MetS) and kidney cancer is increasing, but studies on the effects of MetS and its components on kidney cancer development have had ambiguous results. Overall, 7,613,865 patients from the Korean National Health Insurance System were analyzed and followed up until...
Main Authors: | Tae Ryom Oh, Kyung-Do Han, Hong Sang Choi, Chang Seong Kim, Eun Hui Bae, Seong Kwon Ma, Soo Wan Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/9/1329 |
Similar Items
-
Association between metabolic syndrome and knee osteoarthritis: A cross-sectional nationwide survey study
by: Byung Joo Lee, et al.
Published: (2019-05-01) -
The association of metabolic syndrome components and chronic kidney disease in patients with hypertension
by: Kun Xie, et al.
Published: (2019-12-01) -
Hypoadiponectinemia and the presence of metabolic syndrome in patients with chronic kidney disease: results from the KNOW-CKD study
by: Chang-Yun Yoon, et al.
Published: (2016-11-01) -
Sex Differences in Associations Among Obesity, Metabolic Abnormalities, and Chronic Kidney Disease in Japanese Men and Women
by: Masaru Sakurai
Published: (2016-08-01) -
Reduced risk for chronic kidney disease after recovery from metabolic syndrome: A nationwide population-based study
by: Sehoon Park, et al.
Published: (2020-06-01)